Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA

INTRODUCTION: Promising HIV vaccine candidates are steadily progressing through the clinical trial pipeline. Once available, HIV vaccines will be an important complement but also potential competitor to other biomedical prevention tools such as pre‐exposure prophylaxis (PrEP). Accordingly, the value...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamson, Blythe, Garrison, Louis, Barnabas, Ruanne V, Carlson, Josh J, Kublin, James, Dimitrov, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689690/
https://www.ncbi.nlm.nih.gov/pubmed/31402591
http://dx.doi.org/10.1002/jia2.25373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689690/
https://www.ncbi.nlm.nih.gov/pubmed/31402591
http://dx.doi.org/10.1002/jia2.25373

Ejemplares similares